Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
European Journal of Internal Medicine
|
November 7, 2021
Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Cell Reports Methods
|
September 26, 2023
Accurate age prediction from blood using a small set of DNA methylation sites and a cohort-based machine learning algorithm
Miri Varshavsky, Gil Harari, Benjamin Glaser, et al.
Journal of Clinical Medicine
|
June 2, 2021
Bodyweight Measures and Lifestyle Habits in Individuals with Multiple Sclerosis and Moderate to Severe Disability
Moran Livne-Margolin, Itay Tokatly Latzer, Orit Pinhas-Hamiel, et al.
Journal of Neuroimmunology
|
September 26, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4
David Magalashvili, Mathilda Mandel, Sapir Dreyer-Alster, et al.
European Neurology
|
January 3, 2023
Radiological Disease Activity in Secondary Progressive Multiple Sclerosis
Daniela Noa Zohar, David Magalashvili, Sapir Dreyer-Alster, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 28, 2025
Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal study
Anat Achiron, Yehuda Warszawer, Yael Nissan, et al.
Clinical Interventions in Aging
|
June 28, 2014
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial
Alan G Wade, Mildred Farmer, Gil Harari, et al.
Chemical Science
|
November 7, 2025
Correction: Molecular Aharonov-Bohm-type interferometers based on porphyrin nanorings
Chi Y Cheng, Gil Harari, Igor Rončević, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 2, 2018
Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy
Anat Achiron, Ida Sarova-Pinhas, David Magalashvili, et al.
Chemical Science
|
February 7, 2025
Molecular Aharonov-Bohm-type interferometers based on porphyrin nanorings
Chi Y Cheng, Gil Harari, Igor Rončević, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
European Journal of Internal Medicine
|
November 7, 2021
Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Cell Reports Methods
|
September 26, 2023
Accurate age prediction from blood using a small set of DNA methylation sites and a cohort-based machine learning algorithm
Miri Varshavsky, Gil Harari, Benjamin Glaser, et al.
Journal of Clinical Medicine
|
June 2, 2021
Bodyweight Measures and Lifestyle Habits in Individuals with Multiple Sclerosis and Moderate to Severe Disability
Moran Livne-Margolin, Itay Tokatly Latzer, Orit Pinhas-Hamiel, et al.
Journal of Neuroimmunology
|
September 26, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4
David Magalashvili, Mathilda Mandel, Sapir Dreyer-Alster, et al.
European Neurology
|
January 3, 2023
Radiological Disease Activity in Secondary Progressive Multiple Sclerosis
Daniela Noa Zohar, David Magalashvili, Sapir Dreyer-Alster, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 28, 2025
Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal study
Anat Achiron, Yehuda Warszawer, Yael Nissan, et al.
Clinical Interventions in Aging
|
June 28, 2014
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial
Alan G Wade, Mildred Farmer, Gil Harari, et al.
Chemical Science
|
November 7, 2025
Correction: Molecular Aharonov-Bohm-type interferometers based on porphyrin nanorings
Chi Y Cheng, Gil Harari, Igor Rončević, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 2, 2018
Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy
Anat Achiron, Ida Sarova-Pinhas, David Magalashvili, et al.
Chemical Science
|
February 7, 2025
Molecular Aharonov-Bohm-type interferometers based on porphyrin nanorings
Chi Y Cheng, Gil Harari, Igor Rončević, et al.
Page
of 4